Explore more Categories
Artificial Intelligence involves the science and engineering of developing intelligent machines
The manufacturing world is at a cusp of a new revolution that will redefine conventional business models
IoT will have a major impact on businesses and consumers in the future
The world is creating 2.5 exabytes of data daily
Our research seeks to connect-the-dots across multiple trends
Personal Robots are Set to Be a $19 Billion Market
Strategic Analysis of BREXIT and its Implications to Industries, Economies and Societies
Time for a Digital Revolution in the Women’s Health Market
iFrost is a digital platform for interactive and dynamic reporting of data.
The TOEs are a great source of information which gives corporates critical information on companies to action for their strategic investments either as an open source platform or to collaborate and to develop successful products
Innovative Leaders are Transforming the Cardiovascular Patient Journey
save 25 %
* Required Fields
Pay by invoice
Over the last few decades, modernization-driven lifestyle changes have had major implications on people’s health and well-being. Today, chronic health condition such as cardiovascular diseases (CVD) claim more lives than all forms of cancer combined, accounting for 31% of all deaths worldwide. In the United States alone, 800,000 people succumbed to the disease in 2017—representing one out of every three deaths. Increasing comorbidity of CVD with other health complications and disease conditions necessitate multi-parameter monitoring beyond the ECG to make cardiac care more targeted and efficient. As care for lifestyle-driven chronic diseases expands in scope, prevention and recovery are emerging as new focus areas beyond diagnosis and treatment. Changes in the healthcare landscape are shifting clinical diagnosis and treatment toward more patient-centric monitoring solutions. The emergence of digital cardiac solutions such as cardiac remote patient monitoring devices (e.g., wearables and biosensor technologies) and cardiac informatics software and platforms are redefining the point of care from traditional hospitals or clinics to a patient’s home. Cardiac digital monitoring products and services will benefit from this paradigm shift in both point-of-care and ambulatory settings to promote preventive management of CVD and associated risk factors, particularly for older patients living with CVD. Frost & Sullivan notes that the cardiac digital vendor ecosystem is undergoing a transformation led by the digital convergence and shifting care delivery models to manage patients outside hospital walls in an effort to reduce the use of acute care services, control costs, and improve patient outcomes. Cardiac digital solutions that go beyond the device offering and provide patients and providers with data-driven, clinically meaningful and actionable intelligence will have a competitive advantage. Leading vendors in the cardiac monitoring space will continue to expand and provide comprehensive portfolios encompassing product and service solutions and make the cardiovascular information system (CVIS) the single gateway to all cardiovascular clinical pathways and performance management. Cloud-based CVIS platforms that go beyond point systems/devices and seamlessly integrate with a hospital’s existing enterprise architecture to provide integrated pathway management across patient pathways are expected to see substantial growth in the coming years. Complementing the existing cardiac data analytics layer with some artificial intelligence capabilities for clinical decision support will promote prevention and treatment of CVD to the much-anticipated outcomes-based regime.
The research service analyzes the trends driving the top three growth opportunity associated with digital cardiac products and services. Further, the study provides an analysis of major companies segregated by these top 3 themes which include;
Companies mentioned in the study include; Philips Healthcare, GE Healthcare, Hill-Rom, iRhythm Technologies, Inc., BioTelemetry, Bardy Diagnostics, uber Diagnostics (Cardiotrack), Omsignal Inc., Nanowear Inc., Alivecor, Inc., Heartflow Inc., Apple Inc. (smartwatch), and Verily (Study Watch) among others.
Key Issues Addressed
Author: Kamaljit Behera
Global Renal Care Management Growth Opportunities
Research Efforts Fuel the Future of Global Obstructive Lung Disease Management
GROWTH OPPORTUNITIES IN VENTILATORS, BLOOD GLUCOSE TRACKING, ORTHOPEDIC IMPLANTS, AND BRAIN VISUALIZATION PLATFORMS
GROWTH OPPORTUNITIES IN THERAPEUTICS FOR NEURODEGENERATIVE DISORDERS, IMMUNOTHERAPEUTICS, AND ADVANCED BIOLOGICS
Global Wound Care Solutions and New-age Technology Growth Opportunities
Frost Radar™: Next-generation Surgical Robotic Technology Platforms, 2021
INNOVATIONS AND GROWTH OPPORTUNITIES IN CARDIAC MONITORING DEVICES, AI-ENABLED DIAGNOSTICS, AND SURGICAL DEVICES
Wearable Artificial Organ Growth Opportunities
Respiratory Health Management Technology Growth Opportunities
GROWTH OPPORTUNITIES IN RESPIRATORY AND NEUROLOGICAL DISEASE MANAGEMENT, RNA THERAPEUTICS, AND DRUGS FOR OBESITY AND RARE DISEASES
food preservatives market
mobile biometrics market
smart grid market
smart wearables market
commercial uav market
food waste market
Don't have an account? Create One!
Enter your Email Address here to receive a link to change password.
If you are an existing frost.com user, please register using the same email for seamless access
Already have an account? Login!
Use your Linkedin account to login or register within our store.You're just one click away.